Navigation Links
Aureus Pharma Announces Date of 2008 Annual User Symposium
Date:7/2/2008

PARIS, July 2 /PRNewswire/ -- Aureus Pharma, a leading provider of knowledge management solutions to accelerate discovery in the life science industry, announced today that the Aureus Pharma 2008 User Symposium will be held in Paris on October 23rd and 24th.

This symposium follows last year's highly successful inaugural event which was attended by many of Aureus' pharmaceutical and biotech customers from both Europe and North America. The symposium included presentations from industry scientists who described their experience and value perception of Aureus' solutions as applied to their discovery research projects. In addition, challenges and requirements for future developments were discussed.

At the 2008 event, Aureus will introduce several new products and services as well as provide users and prospective users with a better understanding of how Aureus technology can be beneficially implemented within their individual organizations.

"The first Aureus Pharma User Symposium was a great opportunity for our customers to discuss and share the benefits of their respective experiences related to knowledge driven discovery," said Jason Theodosiou, President & CEO of Aureus Pharma. "I am looking forward to this year's meeting as a continued dialog to direct and to improve Aureus Pharma's contribution to the life science industry."

For more information regarding Aureus Pharma's 2008 User Symposium, please visit http://www.aureus-pharma.com

About Aureus Pharma

Aureus Pharma headquartered in Paris, France is a privately held knowledge management based solutions provider for the life sciences industry. Aureus Pharma accelerates new drug discovery by providing knowledge databases which contain high quality quantitative information for both chemistry and biology. Researchers gain rapid access to knowledge for important drug target classes including GPCR, Ion Channel, Kinase as well as other critical pharmaceutical topics including ADME/Drug-Drug Interactions and the hERG Channel. The information contained in the Aureus Pharma system is of primary importance to aid in lead discovery and optimization as well as to build predictive models. For further information on how Aureus Pharma helps researchers turn data into discovery visit http://www.aureus-pharma.com

Media Contact

Mary Donlan

Director of Marketing

Aureus Pharma

Phone : +33-1-40-18-57-59 / +33-6-76-19-51-77

mary.donlan@aureus-pharma.com


'/>"/>
SOURCE Aureus Pharma
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. QSB Anti-Virulence Platform Inhibits Biofilm Formation by Staphylococcus Aureus MRSA and Candida sp
2. Aureus Pharma Announces Renewal and Expansion of Licensing Agreement With Bristol-Myers Squibb for its AurSCOPE Knowledge Databases
3. New ActivePure Technology Proven To Reduce Exposure to Methicillin Resistant Staphylococcus Aureus (MRSA)
4. WuXi PharmaTech (NYSE: WX) Appoints Mr. Bob Zhu as VP of HR
5. Addrenex Pharmaceuticals Licenses New Compound to Sciele Pharma for the Treatment of Hypertension and Other Potential Indications
6. CET Life Sciences Center Welcomes Belmont University School of Pharmacy as New Tenant
7. Pharmasset Joins Russell 3000 Index
8. Peregrine Pharmaceuticals Awarded DTRA Contract Worth up to $44.4 Million to Develop Bavituximab for Viral Hemorrhagic Fevers
9. Webcast Alert: Isis Pharmaceuticals Announces a Business Update Conference Call
10. Par Pharmaceutical Receives Final Approval to Market Generic Marinol(R) CIII (Dronabinol) Capsules
11. Alseres Pharmaceuticals, Inc. Raises $5 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... ... February 04, 2016 , ... Morf ... today announced an interactive FDA compliance training course, Writing Effective ... Professional Society) accredited interactive course on Morf Playbook—now conveniently available on smartphones and ...
(Date:2/4/2016)... ... February 04, 2016 , ... ... and triple quad LC-MS, host live demos and poster sessions, and present on ... exhibition. The conference takes place March 6 to 10 at the Georgia World ...
(Date:2/4/2016)... MONMOUTH JUNCTION, N.J. , Feb. 4, 2016 ... critical care immunotherapy leader commercializing its flagship CytoSorb® ... and cardiac surgery patients around the world, announced ... PhD, will present at the Source Capital Group,s ... overview and update on the company.  ...
(Date:2/4/2016)... 4, 2016 ContraVir Pharmaceuticals, Inc. (NASDAQ: ... and commercialization of targeted antiviral therapies, announced today that ... 2016, to be held February 8-9, 2016, at the ... Disruptive Growth & Healthcare Conference, taking place in ... James Sapirstein , Chief Executive Officer of ...
Breaking Biology Technology:
(Date:1/18/2016)... 2016  Extenua Inc., a pioneering developer of ... and access of ubiquitous on-premise and cloud storage, today ... Cyber.  ... C4ISR and Cyber initiatives in support of National ... technology solutions," said Steve Visconti , Extenua ...
(Date:1/11/2016)... 2016 Synaptics Incorporated (NASDAQ: SYNA ), ... that its ClearPad ® TouchView ™ 4300 ... separate categories in the 8 th Annual Mobile ... Breakthrough. The Synaptics ® TDDI solution enables faster ... thinner devices, brighter displays and borderless designs. ...
(Date:1/7/2016)... , Jan. 7, 2016 This BCC Research ... for biometric technologies and devices, identifying newer markets and ... various types of biometric devices. Includes forecast from 2015 ... Identify newer markets and explore the expansion of the ... Examine each type of biometric technology, determine its current ...
Breaking Biology News(10 mins):